Eraka Patty Jene Bath, MD
Psychiatry · Los Angeles
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Bath’s office at (310) 825-7952 to ask if they take your plan before you enroll.
California Medical Board record
Licence C52881 · Current
Licensed to practise in California · since 2007 · expires 2027-02-28 · Howard University College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Psychiatry and Neurology - Child and Adolescent Psychiatry
- American Board of Psychiatry and Neurology - Forensic Psychiatry
- American Board of Psychiatry and Neurology - Psychiatry
Drugs they prescribed that Part D paid
$46,833
Pharmacies billed $46,833 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 159) in 2024. At or below the middle of the specialty; the typical psychiatry & neurology clinician is at 0%.
145 generic and 14 brand-name prescriptions · $46,833 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Invega Sustenna | 11 | $39,383 | $3,580 |
| Risperidone | 28 | $272 | $10 |
| Trazodone | 11 | $263 | $24 |
| Divalproex | 11 | $196 | $18 |
| Benztropine Mesylate | 18 | $189 | $10 |
See all 10 drugs
| Invega Sustenna | 11 | $39,383 | $3,580 |
| Risperidone | 28 | $272 | $10 |
| Trazodone | 11 | $263 | $24 |
| Divalproex | 11 | $196 | $18 |
| Benztropine Mesylate | 18 | $189 | $10 |
| Fluoxetine | 17 | $110 | $6 |
| Lamotrigine | 11 | $82 | $7 |
| Topiramate | 11 | $63 | $6 |
| Lorazepam | 12 | $27 | $2 |
| Citalopram Hbr | 13 | $23 | $2 |
Year by year
| 2024 | 159 | None | 0% (0) | 9% | $46,833 |
| 2023 | 149 | None | 0% (0) | 13% | $60,395 |
| 2022 | 195 | None | 0% (0) | 11% | $59,757 |
| 2021 | 225 | None | 0% (0) | 11% | $75,337 |
| 2020 | 361 | None | 0% (0) | 14% | $101,846 |
| 2019 | 354 | 11 | 0% (0) | 15% | $94,584 |
| 2018 | 385 | 12 | 0% (0) | 14% | $95,998 |
| 2017 | 340 | 12 | 0% (0) | 19% | $100,520 |
| 2016 | 276 | 11 | 0% (0) | 15% | $58,427 |
| 2015 | 247 | None | 0% (0) | 21% | $53,079 |
| 2014 | 226 | None | 0% (0) | 12% | $26,487 |
| 2013 | 199 | None | 0% (0) | 16% | $25,378 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Invega Sustenna | 12 | $41,812 | $3,484 |
| Divalproex | 12 | $784 | $65 |
| Risperidone | 20 | $541 | $27 |
| Benztropine Mesylate | 12 | $183 | $15 |
| Lamotrigine | 12 | $172 | $14 |
| Topiramate | 12 | $132 | $11 |
| Fluoxetine | 17 | $106 | $6 |
| Citalopram Hbr | 13 | $24 | $2 |
| Lorazepam | 13 | $23 | $2 |
2022: 11 drugs
| Invega Sustenna | 12 | $38,977 | $3,248 |
| Aripiprazole | 11 | $2,152 | $196 |
| Divalproex | 12 | $840 | $70 |
| Risperidone | 20 | $479 | $24 |
| Benztropine Mesylate | 12 | $196 | $16 |
| Lamotrigine | 12 | $183 | $15 |
| Fluoxetine | 23 | $177 | $8 |
| Topiramate | 12 | $140 | $12 |
| Lorazepam | 21 | $94 | $4 |
| Escitalopram | 20 | $74 | $4 |
| Citalopram Hbr | 11 | $20 | $2 |
2021: 12 drugs
| Invega Sustenna | 13 | $39,794 | $3,061 |
| Aripiprazole | 12 | $2,168 | $181 |
| Divalproex | 12 | $779 | $65 |
| Risperidone | 21 | $506 | $24 |
| Quetiapine | 15 | $467 | $31 |
| Benztropine Mesylate | 14 | $237 | $17 |
| Lamotrigine | 12 | $171 | $14 |
| Topiramate | 12 | $132 | $11 |
| Fluoxetine | 23 | $128 | $6 |
| Lorazepam | 27 | $112 | $4 |
| Escitalopram | 24 | $93 | $4 |
| Citalopram Hbr | 13 | $26 | $2 |
2020: 18 drugs
| Invega Sustenna | 13 | $38,190 | $2,938 |
| Abilify Maintena | 12 | $28,385 | $2,365 |
| Abilify | 20 | $26,172 | $1,309 |
| Aripiprazole | 13 | $4,222 | $325 |
| Quetiapine | 37 | $1,130 | $31 |
| Haloperidol | 12 | $732 | $61 |
| Divalproex | 20 | $549 | $27 |
| Risperidone | 37 | $433 | $12 |
| Benztropine Mesylate | 24 | $335 | $14 |
| Escitalopram | 24 | $310 | $13 |
| Trazodone | 21 | $295 | $14 |
| Lorazepam | 41 | $179 | $4 |
| Prazosin | 12 | $153 | $13 |
| Lamotrigine | 12 | $129 | $11 |
| Fluoxetine | 20 | $121 | $6 |
| Clonidine | 12 | $121 | $10 |
| Topiramate | 12 | $108 | $9 |
| Citalopram Hbr | 13 | $26 | $2 |
2019: 18 drugs
| Invega Sustenna | 12 | $32,179 | $2,682 |
| Abilify Maintena | 12 | $27,192 | $2,266 |
| Abilify | 24 | $26,056 | $1,086 |
| Aripiprazole | 11 | $5,189 | $472 |
| Quetiapine | 30 | $576 | $19 |
| Haloperidol | 12 | $491 | $41 |
| Escitalopram | 24 | $388 | $16 |
| Risperidone | 26 | $381 | $15 |
| Trazodone | 22 | $276 | $13 |
| Divalproex | 12 | $271 | $23 |
| Lorazepam | 45 | $239 | $5 |
| Benztropine Mesylate | 24 | $139 | $6 |
| Prazosin | 12 | $130 | $11 |
| Fluoxetine | 23 | $130 | $6 |
| Clonidine | 12 | $85 | $7 |
| Lamotrigine | 12 | $77 | $6 |
| Topiramate | 12 | $55 | $5 |
| Citalopram Hbr | 20 | $44 | $2 |
2018: 18 drugs
| Invega Sustenna | 12 | $30,355 | $2,530 |
| Abilify | 24 | $26,134 | $1,089 |
| Abilify Maintena | 12 | $22,462 | $1,872 |
| Aripiprazole | 26 | $12,876 | $495 |
| Quetiapine | 35 | $706 | $20 |
| Haloperidol | 12 | $392 | $33 |
| Escitalopram | 24 | $339 | $14 |
| Divalproex | 15 | $320 | $21 |
| Risperidone | 30 | $302 | $10 |
| Lorazepam | 52 | $276 | $5 |
| Benztropine Mesylate | 23 | $181 | $8 |
| Fluoxetine | 35 | $180 | $5 |
| Prazosin | 12 | $141 | $12 |
| Citalopram Hbr | 18 | $92 | $5 |
| Lamotrigine | 12 | $67 | $6 |
| Trazodone | 12 | $60 | $5 |
| Topiramate | 12 | $45 | $4 |
| Clonidine | 11 | $42 | $4 |
2017: 14 drugs
| Invega Sustenna | 12 | $27,759 | $2,313 |
| Abilify | 24 | $26,338 | $1,097 |
| Aripiprazole | 24 | $22,506 | $938 |
| Abilify Maintena | 12 | $17,645 | $1,470 |
| Fluoxetine | 43 | $498 | $12 |
| Escitalopram | 24 | $464 | $19 |
| Divalproex | 19 | $396 | $21 |
| Lorazepam | 46 | $340 | $7 |
| Risperidone | 37 | $300 | $8 |
| Trazodone | 24 | $130 | $5 |
| Benztropine Mesylate | 11 | $112 | $10 |
| Lamotrigine | 11 | $74 | $7 |
| Clonazepam | 12 | $60 | $5 |
| Citalopram Hbr | 11 | $51 | $5 |
2016: 9 drugs
| Abilify | 26 | $29,116 | $1,120 |
| Aripiprazole | 23 | $25,263 | $1,098 |
| Fluoxetine | 47 | $366 | $8 |
| Risperidone | 38 | $326 | $9 |
| Lorazepam | 38 | $311 | $8 |
| Quetiapine | 16 | $263 | $16 |
| Divalproex | 12 | $206 | $17 |
| Trazodone | 21 | $125 | $6 |
| Clonazepam | 15 | $67 | $4 |
2015: 9 drugs
| Abilify | 45 | $49,659 | $1,104 |
| Divalproex | 28 | $1,059 | $38 |
| Risperidone | 45 | $805 | $18 |
| Fluoxetine | 48 | $348 | $7 |
| Gabapentin | 12 | $325 | $27 |
| Buspirone | 11 | $259 | $24 |
| Trazodone | 12 | $149 | $12 |
| Clonazepam | 11 | $136 | $12 |
| Lorazepam | 16 | $66 | $4 |
2014: 9 drugs
| Abilify | 27 | $22,553 | $835 |
| Divalproex | 26 | $796 | $31 |
| Fluoxetine | 48 | $705 | $15 |
| Risperidone | 36 | $655 | $18 |
| Benztropine Mesylate | 13 | $190 | $15 |
| Gabapentin | 11 | $176 | $16 |
| Clonazepam | 12 | $113 | $9 |
| Trazodone | 11 | $112 | $10 |
| Lorazepam | 15 | $77 | $5 |
2013: 6 drugs
| Abilify | 31 | $21,972 | $709 |
| Fluoxetine | 43 | $936 | $22 |
| Risperidone | 30 | $532 | $18 |
| Divalproex | 12 | $382 | $32 |
| Lorazepam | 18 | $263 | $15 |
| Trazodone | 13 | $78 | $6 |
Money from drug and device companies
$96 in 2023
A payment is not proof that care is biased.
| Otsuka America Pharmaceutical | None | $96 | 1 payment
|
See the published payment
| Otsuka America Pharmaceutical | Meals · 2023-05-21 | None | $96 |
Professional record
- NPI
- 1255549093
- Licence
- CA C52881, NY 220122California C52881: Current · expires 2027-02-28
More record details
- Sole proprietor
- No
- Taxonomy
- Psychiatry (2084P0800X); Federal specialty code 2084F0202X (2084F0202X); Federal specialty code 2084P0804X (2084P0804X)
- Mailing address
- 5767 W Century Blvd Ste 400, Los Angeles, CA, 90045
- NPI first listed
- 2007-05-17
- NPI last updated
- 2024-07-15
- NPI record certified
- 2024-07-15
This is when the NPI record was last certified, not a medical board exam.